Danaher (NYSE:DHR) Cut to Hold at Wall Street Zen

Wall Street Zen downgraded shares of Danaher (NYSE:DHR) from a buy rating to a hold rating in a report published on Saturday.

A number of other brokerages also recently commented on DHR. Wells Fargo & Company reaffirmed a “positive” rating on shares of Danaher in a report on Thursday. Evercore ISI increased their price objective on Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. JPMorgan Chase & Co. increased their price objective on Danaher from $260.00 to $270.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. Redburn Partners set a $220.00 price target on shares of Danaher in a research note on Wednesday, October 8th. Finally, Guggenheim reaffirmed a “buy” rating and set a $250.00 price target on shares of Danaher in a research note on Wednesday, July 23rd. Eighteen research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and a consensus price target of $243.39.

Danaher Price Performance

Shares of DHR opened at $221.20 on Friday. The firm has a market capitalization of $156.24 billion, a price-to-earnings ratio of 45.61, a PEG ratio of 3.41 and a beta of 0.77. The firm’s fifty day simple moving average is $202.97 and its 200-day simple moving average is $198.77. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. Danaher has a twelve month low of $171.00 and a twelve month high of $258.23.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The company had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the prior year, the firm posted $1.71 earnings per share. Danaher’s revenue for the quarter was up 4.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities analysts forecast that Danaher will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio is presently 26.39%.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 11.20% of the company’s stock.

Institutional Trading of Danaher

Hedge funds have recently made changes to their positions in the stock. MGO One Seven LLC boosted its stake in Danaher by 485.7% during the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate’s stock valued at $5,145,000 after purchasing an additional 20,813 shares during the period. Chicago Capital LLC lifted its holdings in shares of Danaher by 11.6% during the 2nd quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate’s stock worth $2,634,000 after acquiring an additional 1,391 shares during the period. UniSuper Management Pty Ltd raised its position in Danaher by 1.6% in the first quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate’s stock worth $34,954,000 after purchasing an additional 2,667 shares in the last quarter. Asahi Life Asset Management CO. LTD. acquired a new position in shares of Danaher in the 1st quarter worth approximately $539,000. Finally, Horizon Financial Services LLC boosted its stake in Danaher by 20,400.0% in the 1st quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate’s stock valued at $1,681,000 after buying an additional 8,160 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.